Zarotsky V

References (2)

Title : First clinical evaluation of ganstigmine in patients with probable Alzheimer's disease - Jhee_2003_Clin.Neuropharmacol_26_164
Author(s) : Jhee SS , Fabbri L , Piccinno A , Monici P , Moran S , Zarotsky V , Tan EY , Frackiewicz EJ , Shiovitz T
Ref : Clinical Neuropharmacology , 26 :164 , 2003
Abstract : Jhee_2003_Clin.Neuropharmacol_26_164
ESTHER : Jhee_2003_Clin.Neuropharmacol_26_164
PubMedSearch : Jhee_2003_Clin.Neuropharmacol_26_164
PubMedID: 12782920

Title : Galantamine hydrobromide: an agent for Alzheimer's disease - Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446
Author(s) : Zarotsky V , Sramek JJ , Cutler NR
Ref : Am J Health Syst Pharm , 60 :446 , 2003
Abstract : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446
ESTHER : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446
PubMedSearch : Zarotsky_2003_Am.J.Health.Syst.Pharm_60_446
PubMedID: 12635450